Collectively, these clinical observations indicate that MMP-3 alone—and not both MMP-3 and MMP-10—exhibits opposite expression patterns in stromal fibroblasts and prostate cancer cells and an overall increase in MMP-3 in patient sera. Here, MMP3 is linked to prostate cancer.